Balance Sheet
Cash Flow Statement
Amortization of Deferred ChargesCapital ExpendituresCash from Financing ActivitiesCash from Investing ActivitiesCash from OperationsChange in Account PayablesChange in Accured ExpensesChange in CashChange in ReceivablesDeferred TaxesDepreciation & Amortization (CF)Free Cash FlowGains from Investment SecuritiesGains from Sales and DivestituresLong-Term Debt RepaymentsNet Cash FlowNet IncomeNon-cash ItemsOther Working Capital ChangesShare-based Compensation
Daily Values
Growth Metrics
Income Statement
Others
Ratios

LifeStance Health (LFST) Amortization of Deferred Charges (2020 - 2025)

LifeStance Health (LFST) has disclosed Amortization of Deferred Charges for 6 consecutive years, with $257000.0 as the latest value for Q4 2025.

  • On a quarterly basis, Amortization of Deferred Charges fell 36.07% to $257000.0 in Q4 2025 year-over-year; TTM through Dec 2025 was $1.0 million, a 38.84% decrease, with the full-year FY2025 number at $1.0 million, down 38.84% from a year prior.
  • Amortization of Deferred Charges was $257000.0 for Q4 2025 at LifeStance Health, roughly flat from $256000.0 in the prior quarter.
  • In the past five years, Amortization of Deferred Charges ranged from a high of $603000.0 in Q3 2022 to a low of $251000.0 in Q1 2025.
  • A 5-year average of $413166.7 and a median of $420000.0 in 2024 define the central range for Amortization of Deferred Charges.
  • Peak YoY movement for Amortization of Deferred Charges: skyrocketed 100.0% in 2022, then crashed 40.8% in 2025.
  • LifeStance Health's Amortization of Deferred Charges stood at $299000.0 in 2021, then surged by 100.0% to $598000.0 in 2022, then decreased by 14.88% to $509000.0 in 2023, then decreased by 21.02% to $402000.0 in 2024, then tumbled by 36.07% to $257000.0 in 2025.
  • Per Business Quant, the three most recent readings for LFST's Amortization of Deferred Charges are $257000.0 (Q4 2025), $256000.0 (Q3 2025), and $255000.0 (Q2 2025).